Hand-held Spectroscopic Device for In Vivo and Intraoperative Tumor Detection: Contrast Enhancement, Detection Sensitivity, and Tissue Penetration
- 6 October 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 82 (21), 9058-9065
- https://doi.org/10.1021/ac102058k
Abstract
Surgery is one of the most effective and widely used procedures in treating human cancers, but a major problem is that the surgeon often fails to remove the entire tumor, leaving behind tumor-positive margins, metastatic lymph nodes, and/or satellite tumor nodules. Here we report the use of a hand-held spectroscopic pen device (termed SpectroPen) and near-infrared contrast agents for intraoperative detection of malignant tumors, based on wavelength-resolved measurements of fluorescence and surface-enhanced Raman scattering (SERS) signals. The SpectroPen utilizes a near-infrared diode laser (emitting at 785 nm) coupled to a compact head unit for light excitation and collection. This pen-shaped device effectively removes silica Raman peaks from the fiber optics and attenuates the reflected excitation light, allowing sensitive analysis of both fluorescence and Raman signals. Its overall performance has been evaluated by using a fluorescent contrast agent (indocyanine green, or ICG) as well as a surface-enhanced Raman scattering (SERS) contrast agent (pegylated colloidal gold). Under in vitro conditions, the detection limits are approximately 2−5 × 10−11 M for the indocyanine dye and 0.5−1 × 10−13 M for the SERS contrast agent. Ex vivo tissue penetration data show attenuated but resolvable fluorescence and Raman signals when the contrast agents are buried 5−10 mm deep in fresh animal tissues. In vivo studies using mice bearing bioluminescent 4T1 breast tumors further demonstrate that the tumor borders can be precisely detected preoperatively and intraoperatively, and that the contrast signals are strongly correlated with tumor bioluminescence. After surgery, the SpectroPen device permits further evaluation of both positive and negative tumor margins around the surgical cavity, raising new possibilities for real-time tumor detection and image-guided surgery.Keywords
This publication has 48 references indexed in Scilit:
- Molecular Mapping of Tumor Heterogeneity on Clinical Tissue Specimens with Multiplexed Quantum DotsACS Nano, 2010
- Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In VivoACS Nano, 2010
- Nanotechnology Applications in Surgical OncologyAnnual Review of Medicine, 2010
- Biodistribution of Encapsulated Indocyanine Green in Healthy MiceMolecular Pharmaceutics, 2009
- Effect of hormonal variation on Raman spectra for cervical disease detectionAmerican Journal of Obstetrics and Gynecology, 2009
- Noninvasive evaluation of oral lesions using depth‐sensitive optical spectroscopyCancer, 2009
- Bioconjugated quantum dots for in vivo molecular and cellular imagingAdvanced Drug Delivery Reviews, 2008
- Imaging of Lymph Flow in Breast Cancer Patients after Microdose Administration of a Near-Infrared Fluorophore: Feasibility StudyRadiology, 2008
- Intraoperative Ultrasound Localization of Nonpalpable Breast CancersAnnals of Surgical Oncology, 2007
- Raman Spectroscopy of Some Polymers and Copolymers of Styrene, Butadiene, and MethylmethacrylateApplied Spectroscopy, 1973